Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Cantor Fitzgerald
Baxter
QuintilesIMS
Medtronic
Fuji
Daiichi Sankyo
Moodys

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074292

« Back to Dashboard

NDA 074292 describes DOBUTAMINE HYDROCHLORIDE, which is a drug marketed by Baxter Hlthcare, Hospira, Luitpold, Teligent Pharma Inc, Teva Parenteral, Watson Labs, Watson Labs Inc, and West-ward Pharms Int, and is included in fourteen NDAs. It is available from three suppliers. Additional details are available on the DOBUTAMINE HYDROCHLORIDE profile page.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
Summary for 074292
Tradename:DOBUTAMINE HYDROCHLORIDE
Applicant:Hospira
Ingredient:dobutamine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 074292
Mechanism of ActionAdrenergic beta-Agonists
Medical Subject Heading (MeSH) Categories for 074292
Suppliers and Packaging for NDA: 074292
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074292 ANDA Hospira, Inc. 0409-2025 N 0409-2025-20
DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074292 ANDA Hospira, Inc. 0409-2025 N 0409-2025-54

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 12.5MG BASE/ML
Approval Date:Feb 16, 1995TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Accenture
Medtronic
Baxter
Mallinckrodt
Colorcon
UBS
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.